Cargando…
Evidence Regarding Pharmacogenetics in Pain Management and Cancer
Patients experience interindividual variation in response to analgesics, which may be partially explained by genetics. This commentary discusses a recently published trial on COMT genotype and opioid dose requirements and describes the potential role for COMT and other genes (eg, CYP2D6) on opioid t...
Autores principales: | Smith, D Max, Figg, William D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020807/ https://www.ncbi.nlm.nih.gov/pubmed/36718020 http://dx.doi.org/10.1093/oncolo/oyac277 |
Ejemplares similares
-
Zinc–rs13266634 and the Arrival of Diabetes Pharmacogenetics: The “Zinc Mystique”
por: Maruthur, Nisa M., et al.
Publicado: (2014) -
A pharmacogenetics approach to pain management
por: Yoshida, Kaori, et al.
Publicado: (2018) -
Reproducibility of pharmacogenetics findings for paclitaxel in a heterogeneous population of patients with lung cancer
por: Sissung, Tristan M., et al.
Publicado: (2019) -
Pharmacogenetic Perturbations in Humans as a Tool to Generate Mechanistic Insight
por: Florez, Jose C.
Publicado: (2013) -
Knowledge and attitude regarding pharmacogenetics among formerly pregnant women in the Netherlands and their interest in pharmacogenetic research
por: Daud, Aizati N. A., et al.
Publicado: (2017)